{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:06:10Z","timestamp":1771434370439,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.urolonc.2025.12.005","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:38:11Z","timestamp":1767011891000},"page":"110969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of insurance status on testicular cancer outcomes: A single-institution, dual-site study"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8045-2757","authenticated-orcid":false,"given":"Ifeanyi Chidera","family":"Ibezue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zine-Eddine","family":"Khene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Bhanvadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Woldu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Bagrodia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waddah","family":"Arafat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farrukh","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Gaston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.12.005_bib0002","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/cncr.30597","article-title":"Future of testicular germ cell tumor incidence in the United States: forecast through 2026","volume":"123","author":"Ghazarian","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2025.12.005_bib0003","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers","volume":"15","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2025.12.005_bib0004","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00432-020-03343-2","article-title":"Improved outcomes in metastatic germ cell cancer: results from a large cohort study","volume":"147","author":"Hentrich","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.12.005_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/107755879305000204","article-title":"Defining underinsurance: a conceptual framework for policy and empirical analysis","volume":"50","author":"Bashshur","year":"1993","journal-title":"Med Care Rev"},{"issue":"4","key":"10.1016\/j.urolonc.2025.12.005_bib0006","doi-asserted-by":"crossref","first-page":"502","DOI":"10.6004\/jnccn.2012.0050","article-title":"Testicular cancer","volume":"10","author":"Motzer","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.urolonc.2025.12.005_bib0007","doi-asserted-by":"crossref","first-page":"201.e201","DOI":"10.1016\/j.urolonc.2022.02.019","article-title":"Predictive factors of diagnostic delay and effect on treatment patterns in testicular germ cell tumor patients","volume":"40","author":"Badia","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.12.005_bib0008","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.urology.2017.08.059","article-title":"Differences at presentation and treatment of testicular cancer in Hispanic men: institutional and national hospital-based analyses","volume":"112","author":"Woldu","year":"2018","journal-title":"Urology"},{"issue":"6465","key":"10.1016\/j.urolonc.2025.12.005_bib0009","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bmj.290.6465.356","article-title":"Factors contributing to delay in diagnosis of testicular tumours","volume":"290","author":"Oliver","year":"1985","journal-title":"British Med J (Clin Res ed)"},{"issue":"1","key":"10.1016\/j.urolonc.2025.12.005_bib0010","doi-asserted-by":"crossref","first-page":"23.e15","DOI":"10.1016\/j.urolonc.2012.08.012","article-title":"Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base","volume":"32","author":"Lerro","year":"2014","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.12.005_bib0011","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1200\/JCO.23.00959","article-title":"Prognostic factors for relapse in patients with clinical stage I testicular seminoma: a nationwide, population-based cohort study","volume":"42","author":"Wagner","year":"2024","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.urolonc.2025.12.005_bib0012","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.6004\/jnccn.2019.0058","article-title":"Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Gilligan","year":"2019","journal-title":"J Nat Comprehensive Cancer Netw: JNCCN"},{"issue":"29","key":"10.1016\/j.urolonc.2025.12.005_bib0013","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1200\/JCO.2010.32.6678","article-title":"Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database","author":"Lorch","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.12.005_bib0014","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/jamasurg.2015.3209","article-title":"Effect of hospital safety-net burden on cost and outcomes after surgery","volume":"151","author":"Hoehn","year":"2016","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.urolonc.2025.12.005_bib0015","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.juro.2015.04.098","article-title":"Utilization and outcomes of inpatient urological care at Safety Net hospitals","volume":"194","author":"Herrel","year":"2015","journal-title":"J Urol"},{"issue":"19","key":"10.1016\/j.urolonc.2025.12.005_bib0016","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1002\/cncr.33076","article-title":"Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital","volume":"126","author":"Chertack","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2025.12.005_bib0017","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2017.77.0735","article-title":"Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study","volume":"36","author":"Kerns","year":"2018","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2025.12.005_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238813","article-title":"Insurance coverage, stage at diagnosis, and time to treatment following dependent coverage and Medicaid expansion for men with testicular cancer","volume":"15","author":"Weiner","year":"2020","journal-title":"PLoS One"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:15:09Z","timestamp":1771431309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925004843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1078143925004843"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.12.005","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of insurance status on testicular cancer outcomes: A single-institution, dual-site study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110969"}}